Home Healthcare Healthcare IT Therapeutics Apps Market

Therapeutics Apps Market Size, Share & Trends Analysis Report By Therapeutic Category (Weight Loss, Women Health, Disease Management, Mental Health), By Services Provided (Remote Monitoring, Consultation, Drug Reference, Diagnostics, Medical Monitoring Systems, Clinical Support Systems, Electronic Medical Records), By End-Users (Healthcare Authorities, Medicare Practitioners, Therapists, Patients, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Dhanashri Chandgude | Format:

Therapeutics Apps Market Size

The global therapeutics apps market size was valued at USD 10.15 billion in 2025 and is projected to grow from USD 12.49 billion in 2026 to USD 65.89 billion by 2034, registering a CAGR of 23.1% during the forecast period from 2026 to 2034. North America dominated the therapeutics apps market with a market share of 38.5% in 2025.

Therapeutics apps are mobile applications designed to help manage, monitor, and improve health outcomes for individuals dealing with various medical conditions. These apps typically offer services such as remote monitoring, personalized health tracking, virtual consultations, and access to educational resources. They cover a broad range of therapeutic categories, including weight loss, women’s health, disease management (like diabetes and cardiovascular issues), and mental health support. By integrating features like data analytics and real-time health monitoring, therapeutics apps empower users to take control of their health and enable healthcare providers to deliver more efficient, personalized care.

The market is driven by the increasing prevalence of chronic diseases and the growing demand for personalized healthcare solutions. As conditions like diabetes, cardiovascular diseases, and mental health issues become more widespread, patients and healthcare providers are turning to digital tools for ongoing management and support. Moreover, the rising awareness of the benefits of self-care and preventive health measures encourages individuals to use therapeutic apps to track their health and wellness. This shift towards proactive health management is accelerating the adoption of these apps across various segments.

Therapeutics Apps Market Size

Download a Free Sample To learn more about this report.

Segmentation Analysis

By Therapeutic Category

The weight loss segment is the dominant category in the global therapeutics apps market. Obesity management and weight control apps, alongside fitness and nutrition tracking features, have gained significant traction. These apps help users monitor their calorie intake, exercise routines, and overall health progress. As obesity continues to rise globally, the demand for digital solutions that provide personalized weight management advice and fitness guidance has surged, making it a key driver of the market’s growth.

Therapeutics Apps Market Size By Segments

Request Customizationto receive a tailored report.

By Services Provided

Remote monitoring is the leading service offered by therapeutics apps, providing patients with continuous health tracking from the comfort of their homes. This service is especially crucial for managing chronic diseases like diabetes, cardiovascular conditions, and respiratory issues. By using wearable devices and mobile apps, patients can track vital signs, receive alerts, and share data with healthcare providers. The growing demand for personalized, real-time health management has solidified remote monitoring as a dominant service in the market.

By End-Users

Healthcare authorities represent the dominant end-user of therapeutics apps. These organizations leverage digital health tools to enhance patient care, streamline processes, and improve overall healthcare delivery. With the increasing integration of mobile health apps into national health systems, authorities are focusing on adopting these technologies to monitor public health, manage chronic conditions, and reduce healthcare costs. Their widespread adoption of therapeutic apps is critical in transforming healthcare delivery models globally, fostering patient-centric care.

Therapeutics Apps Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

North America Therapeutics Apps Market: Dominant Region

North America leads the global therapeutics apps market, driven by advanced healthcare infrastructure, high smartphone penetration, and early adoption of digital health innovations. The region benefits from widespread insurance coverage for digital therapeutics and supportive regulatory frameworks that encourage innovation. Leading hospitals and research institutions frequently integrate therapeutic apps for chronic disease management, mental health, and rehabilitation, supported by strong investment in AI and health tech startups. The increasing prevalence of lifestyle-related conditions also fuels consistent demand for remote, app-based therapeutic solutions.

U.s. Therapeutics Apps Market Trends

The U.S. market is experiencing significant growth, driven by regulatory advancements and technological innovations. The FDA's approval of Rejoyn, a prescription-only digital therapeutic app for major depressive disorder, exemplifies this trend. Moreover, Medicare's proposal to reimburse digital mental health therapies indicates a shift towards integrating digital solutions into healthcare.

  • Canada’s therapeutics apps market is expanding, supported by a robust healthcare infrastructure and increasing adoption of digital health solutions. The integration of AI and data analytics into therapeutic apps is enhancing personalized care, particularly in managing chronic conditions and mental health. Government initiatives promoting digital health literacy and infrastructure are further propelling market growth.
North America Therapeutics Apps Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific Therapeutics Apps Market: Significantly Growing Region

Asia-Pacific is witnessing rapid growth, fueled by expanding digital infrastructure, rising healthcare awareness, and a large population base with increasing smartphone access. Governments are launching nationwide digital health initiatives to support remote care delivery, especially in rural and underserved areas. In recent years, several startups and healthtech companies have introduced AI-enabled therapeutic platforms focused on chronic conditions, mental health, and women’s health. This accelerating innovation, combined with growing consumer acceptance, is positioning the region as a key growth frontier for mobile-based therapeutic interventions.

China Therapeutics Apps Market Trends

China’s market is expanding rapidly, driven by government programs like "Healthy China 2030" and growing investments in digital health technologies. The adoption of telemedicine, mobile health apps, and AI is improving healthcare accessibility, particularly in rural regions. Platforms such as Ping An Good Doctor demonstrate the successful integration of these technologies, offering a model for broader health system enhancement.

  • India’s therapeutics apps market is experiencing rapid growth, with increasing smartphone penetration and healthcare awareness among a large, diverse population. Demand for therapeutic apps is driven by a focus on preventive care, mental health, and chronic disease management. The government’s push toward digital health initiatives and telemedicine platforms further accelerates this market’s growth, alongside a rise in app-based solutions for rural and underserved communities.

Europe Therapeutics Apps Market: Substantial Potential for Growth

Europe holds strong potential, supported by favorable regulatory frameworks, increased digital health funding, and a rising focus on preventive care. The region has seen a steady rise in the adoption of digital therapeutics in areas such as mental health, chronic disease management, and neurorehabilitation. Collaborations between public health bodies and digital health startups are driving innovation, especially in personalized care. The emphasis on data protection and clinical validation provides a solid foundation for long-term adoption and integration of therapeutics apps into mainstream healthcare services.

U.k. Therapeutics Apps Market Trends

The U.K. market is advancing, with digital tools like Sleepio being recommended by NICE as effective alternatives to traditional treatments for insomnia. The integration of AI-powered chatbots in the NHS is improving patient triage and access to mental health services. Collaborations between biotech firms and pharmaceutical companies are further enhancing the digital therapeutics landscape.

  • Germany’s therapeutics apps industry is growing steadily, bolstered by strong healthcare regulations and high digital health adoption. Germany’s national digital health initiative encourages the use of medical apps for chronic disease management and mental health. The country’s approval process for digital health apps and reimbursement policies further contributes to growth, while innovative therapeutic solutions using AI and data analytics become more prevalent.

List of Key and Emerging Players in Therapeutics Apps Market

AgaMatrix, Inc
Medtronic plc
AirStrip Technologies
Nike, Inc
Omron Corporation
Withings
BioTelemetry, Inc
iHealth Labs Inc
athenahealth, Inc
Cerner Corporation
Philips Healthcare
AT&T, Inc.
Allscripts Healthcare Solutions

Key Industry Developments

June 2026
Shionogi & Co., Ltd. launched ENDEAVORRIDE, Japan's first digital therapeutic app approved as an adjunctive treatment for pediatric ADHD, expanding the adoption of prescription digital therapeutics in Asia.
May 2026
DarioHealth expanded its AI-powered digital therapeutics platform with enhanced GLP-1 companion features, integrating personalized coaching, medication adherence support, and remote monitoring for obesity and cardiometabolic disease management.
February 2026
Samsung partnered with PharmEasy and Tata 1mg to introduce the Find Care feature within the Samsung Health app, enabling medicine ordering, diagnostic test booking, and online consultations through a single digital health platform.
October 2025
Otsuka Pharmaceutical and Click Therapeutics expanded their collaboration to accelerate the development and commercialization of prescription digital therapeutics targeting major depressive disorder and other neuropsychiatric conditions.

Report Scope

Segmentation

By Therapeutic Category 4
  • Weight Loss
  • Women Health
  • Disease Management
  • Mental Health
By Services Provided 7
  • Remote Monitoring
  • Consultation
  • Drug Reference
  • Diagnostics
  • Medical Monitoring Systems
  • Clinical Support Systems
  • Electronic Medical Records
By End-Users 5
  • Healthcare Authorities
  • Medicare Practitioners
  • Therapists
  • Patients
  • Others

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage AgaMatrix, Inc · Medtronic plc · AirStrip Technologies · Nike, Inc · Omron Corporation
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The therapeutics apps market size is valued at USD 12.49 Billion in 2026 and is projected to reach USD 65.89 Billion by 2034, at a CAGR of 23.1% during the forecast period 2026-2034.
North America dominated the market with a share of 38.5% in 2025.
The leading players in this market are AgaMatrix, Inc, Medtronic plc, AirStrip Technologies, Nike.
The therapeutics apps market is projected to grow at a CAGR of 23.1% during the forecast period of 2026 2034.
About the Author
Dhanashri Chandgude
Dhanashri Chandgude
Senior Research Associate

Dhanashri Chandgude is a healthcare research professional with over four years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.

Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.

Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now